Article Sidebar

PDF
Date Published: 28/12/2022
Abstract Views: 546
Views PDF: 403
DOI: https://doi.org/10.51298/vmj.v520i1.3734
Issue
Vol. 520 No. 1A (2022)
Section
Các bài báo
How to Cite
Hồng Hoa, N. ., & Thị Vân Khanh, Đinh . (2022). ACCEPTABILITY OF IMPLANON SUBDERMAL IMPLANT AMONG 6-12 WEEKS POSTPARTUM WOMEN AT MEKONG HOSPITAL. Vietnam Medical Journal, 520(1A). https://doi.org/10.51298/vmj.v520i1.3734

ACCEPTABILITY OF IMPLANON SUBDERMAL IMPLANT AMONG 6-12 WEEKS POSTPARTUM WOMEN AT MEKONG HOSPITAL

Nguyễn Hồng Hoa1,, Đinh Thị Vân Khanh2
1 University of Medicine and Pharmacy at Ho Chi Minh City
2 MeKong Obstetrics and Gynecology Hospital

Main Article Content

Abstract

Objective: To determine the acceptability of Implanon subdermal implant in 6-12 week-postpartum women. Methods: A cross-sectional study was conducted on 393 postpartum women who visited MeKong hospital after giving-birth 6-12 weeks, 18 years of age or older, from November 2021 to June 2022. Results: Acceptability rate of Implanon subdermal implant was 21,2%; the mean age was 31 years; 75,3% of women with above high school; 46,4% of women with one child; 77,6% women using contraception before this pregnancy. The percentage of women with correct knowledge about implant is 32,3%, the positive attitude towards this method is 41,5%. There was a significant correlation between good knowledge and acceptability of Implanon (PR=3,08, p<0,001). Conclusion: Improving knowledge of subdermal implant by advising implant to women from antenatal check-up, before discharge from hospital, and postnatal follow-up visit is recommended.

Article Details

Keywords

acceptability, knowledge, attitude, subdermal, Implanon, postpartum women, MeKong hospital

References

1. Shrah LB. Family Planning Advice and Postpartum Contraceptive Use Among Low-Income Women in Mexico. International Family Planning Perspectives 2007; 33(1): 6-12.
2. Faculty of sexual and reproductive health care clinical effectiveness unit, postnatal sexual and reproductive health. (2009) Faculty of sexual and reproductive health. Available at: http://www.fsrh.org/pdfs/ ceuguidance postnatal og.pdf [Accessed, 11 November 2014].
3. Andrew MK (2015). Post abortion contraception. UpToDate. available at: http://www.uptodate.com/ contents/postabortion-contraception [Accessed, 12 July 2015].
4. Brunson MR, Klein DA, Olsen CH, Weir LF, Roberts TA. Postpartum contraception: initiation and effectiveness in a large universal healthcare system. Comparative Study. Am J Obstet Gynecol. 2017;217(1):28.
5. ACOG (2017), Long-Acting Reversible Contraception: Implants and Intrauterine Devices, Practice Bulletin Number 186, November 2017.
6. Hồng Thành Tài (2015), "Kiến thức và thái độ của phụ nữ về que cấy tránh thai ở phụ nữ đang dùng Implanon tại bệnh viện Từ Dũ", Luận văn thạc sĩ y học, Đại học y dược thành phố Hồ Chí minh, tr.75.
7. Đỗ Thị Lan Hương (2017), "Tỷ lệ áp dụng biện pháp tránh thai hiện đại và các yếu tố liên quan ở phụ nữ sau mổ lấy thai tại bệnh viện Từ Dũ", Luận văn thạc sĩ y học, Đại học y dược thành phố Hồ Chí minh, tr.40-62.
8. Makola E. Knowledge, attitude, and practice of women regarding contraceptive implants, in Odendaalsrus, Lejweleputswa District, Free State Province. Master’s in medicine (Family medicine), University of Free State, https://scholar.ufs.ac.za
9. Barbieri MM, Herculano TB, Dantas Silva A, Bahamondes L, Juliato CRT, Surita FG. Acceptability of ENG-releasing subdermal implants among postpartum Brazilian young women during the COVID-19 pandemic. Int J Gynaecol Obstet. 2021 Jul;154(1):106-112. doi: 10.1002/ ijgo.13663. Epub 2021 Apr 29. PMID: 33656758; PMCID: PMC9087758.
10. DHMH/FHA/CMCH Mariland family planning & reproductive health program clinical guidelines. Postpartum Evaluation and Contraception, 2012.